Hereditary gingival fibromatosis: A case report with seven-year follow-up

• Main Authors: De Toledo, O.A (Author), Gagliardi, R.M (Author), Gonçalves, C.F (Author), Martins, R.F.S (Author), Mundim, A.P (Author), Santos, P.S.S (Author)
• Format: Article
• Language: English
• Published: University of Zagreb 2018
• Subjects: adult; anticonvulsive agent; Article; calcium; carbamazepine; case report; clinical article; cyclobenzaprine; disease severity; epilepsy; female; follow up; gingiva fibromatosis; gingiva hyperplasia; Gingival Fibromatosis; Gingival Hyper-plasia; gingivectomy; health status; human; iron; jaw pain; Karnofsky Performance Status; medical history; mental deficiency; microcephaly; mineral; mouth examination; phenobarbital; ranitidine; seizure; tonic clonic seizure
• Online Access: View Fulltext in Publisher

 Introduction: Hereditary gingival fibromatosis (HGF) is a rare disease characterized by gingival enlargement, normal color with benign and firm consistency. This growth may be exacerbated by use of drugs and plaque build-up. The treatment for this clinical condition is surgical excision of the enlarged gingival tissue or the extraction of all teeth. Case Report: A 20-year-old Brazilian female handicapped patient with a chief complaint of exaggerated gingival enlargement who had been prescribed Carbamazepine and Gardenal was referred to our center. According to the clinical presentation and family history, the final diagnosis of gingival enlargement was HGF. Full dental treatment was performed, including basic periodontal treatment, restorations, sealants, and gingivoplasty with internal bevel. Special care was taken to ensure that there was no change in patient’s anticonvulsant medication. The patient has been monitored for seven years without signs of recurrence of gingival hyperplasia due to constant professional and home control of plaque. © 2018 University of Zagreb. All rights reserved.